The Chicago Entrepreneur

Troubled Spanish pharma company Grifols says it may go private for $6 billion

Shares of Grifols were halted on Monday, following news the indebted Spanish blood plasma pharmaceutical company may go private.

Previous post Bond yields edge higher with investors focused on inflation, election
Next post Hedge funds pile into commodity sensitive stocks at fastest pace in five months: Goldman data